PC3 cells, which are derived from prostate cancer cells, exhibit a significantly elevated Akt activity due to the loss of PTEN, a negative regulator of Akt,32, 33 whereas the colon cancer-derived HCT116 cells exhibit a normal level of Akt activity. This evidence concerns the gene PTEN and prostate carcinoma.